Dawnrays Pharmaceutical Holdings Limited announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was CNY 1,024.270 million compared to CNY 950.007 million a year ago. Net income was CNY 268.130 million compared to CNY 255.430 million a year ago. Basic earnings per share from continuing operations was CNY 0.1736 compared to CNY 0.1621 a year ago. Diluted earnings per share from continuing operations was CNY 0.1735 compared to CNY 0.1621 a year ago.